Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / May / A Singular Approach to Combatting Infectious Disease
Omics Translational Science Voices in the Community Data and AI

A Singular Approach to Combatting Infectious Disease

 How single-cell analysis is evolving to improve vaccine development

By Anis Larbi, LaToya Montgomery 05/18/2026 3 min read
  • Full Article
  • Summary
  • Listen
  • Quiz
  • Top Thought Leaders

Share

Objective:

To explore the role of single-cell analysis in enhancing vaccine development and understanding immune responses to emerging pathogens.

Key Findings:
  • Single-cell analysis provides detailed insights into the heterogeneity of immune responses.
  • Flow cytometry and single-cell RNA sequencing are pivotal in understanding immune cell interactions and functions.
  • Studies have shown distinct B-cell populations and transcriptional signatures that correlate with vaccine responses.
Interpretation:

Advancements in single-cell technologies can significantly enhance our understanding of immune responses, leading to more effective and personalized vaccines.

Limitations:
  • Single-cell research requires specialized skills and advanced equipment, limiting accessibility for many labs.
  • The integration of diverse data types and AI models is still in developmental stages and may face technical challenges.
Conclusion:

Embracing single-cell analysis and systems vaccinology can expedite vaccine development and improve preparedness against infectious diseases.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. AJ Konecny et al., “50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells,” Cytometry A, 105, 6, 430–436 (2024). DOI: 10.1002/cyto.a.24841
  2. JF Scheid et al., “B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV,” Cell, 184, 12, p3205-3221 (2021). DOI: 10.1016/j.cell.2021.04.032
  3. Y Kotliarov et al., “Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus,” Nat Med, 26, 618–629 (2020). DOI: 10.1038/s41591-020-0769-8
  4. www.humancellatlas.org 

About the Author(s)

Anis Larbi

Senior Manager in Medical and Scientific Affairs at Beckman Coulter Life Sciences.

More Articles by Anis Larbi

LaToya Montgomery

Medical & Scientific Writerat Beckman Coulter Life Sciences

More Articles by LaToya Montgomery

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.